These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 38615945)

  • 1. Hepatic Klf10-Fh1 axis promotes exercise-mediated amelioration of NASH in mice.
    Luo HY; Mu WJ; Chen M; Zhu JY; Li Y; Li S; Yan LJ; Li RY; Yin MT; Li X; Chen HM; Guo L
    Metabolism; 2024 Jun; 155():155916. PubMed ID: 38615945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. KLF10 promotes nonalcoholic steatohepatitis progression through transcriptional activation of zDHHC7.
    Yang S; Jia L; Xiang J; Yang G; Qiu S; Kang L; Zheng P; Liang Z; Lu Y
    EMBO Rep; 2022 Jun; 23(6):e54229. PubMed ID: 35492028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Krüppel-like factor 10 protects against metabolic dysfunction-associated steatohepatitis by regulating HNF4α-mediated metabolic pathways.
    Pan X; Hu S; Xu Y; Gopoju R; Zhu Y; Cassim Bawa FN; Wang H; Wang J; Batayneh Z; Clark A; Zeng Y; Lin L; Wang X; Yin L; Zhang Y
    Metabolism; 2024 Jun; 155():155909. PubMed ID: 38582490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progression of diet induced nonalcoholic steatohepatitis is accompanied by increased expression of Kruppel-like-factor 10 in mice.
    Kim JK; Lee KS; Chang HY; Lee WK; Lee JI
    J Transl Med; 2014 Jul; 12():186. PubMed ID: 24986741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deletion of KLF10 Leads to Stress-Induced Liver Fibrosis upon High Sucrose Feeding.
    Lee J; Oh AR; Lee HY; Moon YA; Lee HJ; Cha JY
    Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33396939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MCD diet-induced steatohepatitis generates a diurnal rhythm of associated biomarkers and worsens liver injury in Klf10 deficient mice.
    Leclère PS; Rousseau D; Patouraux S; Guérin S; Bonnafous S; Gréchez-Cassiau A; Ruberto AA; Luci C; Subramaniam M; Tran A; Delaunay F; Gual P; Teboul M
    Sci Rep; 2020 Jul; 10(1):12139. PubMed ID: 32699233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. KLF10 transcription factor regulates hepatic glucose metabolism in mice.
    Yang X; Chen Q; Sun L; Zhang H; Yao L; Cui X; Gao Y; Fang F; Chang Y
    Diabetologia; 2017 Dec; 60(12):2443-2452. PubMed ID: 28836014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tcf7l2 in hepatocytes regulates de novo lipogenesis in diet-induced non-alcoholic fatty liver disease in mice.
    Lee DS; An TH; Kim H; Jung E; Kim G; Oh SY; Kim JS; Chun HJ; Jung J; Lee EW; Han BS; Han DH; Lee YH; Han TS; Hur K; Lee CH; Kim DS; Kim WK; Park JW; Koo SH; Seong JK; Lee SC; Kim H; Bae KH; Oh KJ
    Diabetologia; 2023 May; 66(5):931-954. PubMed ID: 36759348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. KLF10 Inhibits TGF-β-Mediated Activation of Hepatic Stellate Cells via Suppression of ATF3 Expression.
    Hwang S; Park S; Yaseen U; Lee HJ; Cha JY
    Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37628783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cdo1-Camkk2-AMPK axis confers the protective effects of exercise against NAFLD in mice.
    Chen M; Zhu JY; Mu WJ; Luo HY; Li Y; Li S; Yan LJ; Li RY; Guo L
    Nat Commun; 2023 Dec; 14(1):8391. PubMed ID: 38110408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The hepatocyte IKK:NF-κB axis promotes liver steatosis by stimulating de novo lipogenesis and cholesterol synthesis.
    Heida A; Gruben N; Catrysse L; Koehorst M; Koster M; Kloosterhuis NJ; Gerding A; Havinga R; Bloks VW; Bongiovanni L; Wolters JC; van Dijk T; van Loo G; de Bruin A; Kuipers F; Koonen DPY; van de Sluis B
    Mol Metab; 2021 Dec; 54():101349. PubMed ID: 34626855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exercise of high intensity ameliorates hepatic inflammation and the progression of NASH.
    Fredrickson G; Barrow F; Dietsche K; Parthiban P; Khan S; Robert S; Demirchian M; Rhoades H; Wang H; Adeyi O; Revelo XS
    Mol Metab; 2021 Nov; 53():101270. PubMed ID: 34118476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The transcription factor c-Jun/AP-1 promotes liver fibrosis during non-alcoholic steatohepatitis by regulating Osteopontin expression.
    Schulien I; Hockenjos B; Schmitt-Graeff A; Perdekamp MG; Follo M; Thimme R; Hasselblatt P
    Cell Death Differ; 2019 Sep; 26(9):1688-1699. PubMed ID: 30778201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disruption of hepatic small heterodimer partner induces dissociation of steatosis and inflammation in experimental nonalcoholic steatohepatitis.
    Magee N; Zou A; Ghosh P; Ahamed F; Delker D; Zhang Y
    J Biol Chem; 2020 Jan; 295(4):994-1008. PubMed ID: 31831621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of XBP1 in regulating the progression of non-alcoholic steatohepatitis.
    Wang Q; Zhou H; Bu Q; Wei S; Li L; Zhou J; Zhou S; Su W; Liu M; Liu Z; Wang M; Lu L
    J Hepatol; 2022 Aug; 77(2):312-325. PubMed ID: 35292349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acetyl-CoA carboxylase inhibition disrupts metabolic reprogramming during hepatic stellate cell activation.
    Bates J; Vijayakumar A; Ghoshal S; Marchand B; Yi S; Kornyeyev D; Zagorska A; Hollenback D; Walker K; Liu K; Pendem S; Newstrom D; Brockett R; Mikaelian I; Kusam S; Ramirez R; Lopez D; Li L; Fuchs BC; Breckenridge DG
    J Hepatol; 2020 Oct; 73(4):896-905. PubMed ID: 32376414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. KLF10 Deficiency in CD4
    Wara AK; Wang S; Wu C; Fang F; Haemmig S; Weber BN; Aydogan CO; Tesmenitsky Y; Aliakbarian H; Hawse JR; Subramaniam M; Zhao L; Sage PT; Tavakkoli A; Garza A; Lynch L; Banks AS; Feinberg MW
    Cell Rep; 2020 Dec; 33(13):108550. PubMed ID: 33378664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. KLF10 integrates circadian timing and sugar signaling to coordinate hepatic metabolism.
    Ruberto AA; Gréchez-Cassiau A; Guérin S; Martin L; Revel JS; Mehiri M; Subramaniam M; Delaunay F; Teboul M
    Elife; 2021 Aug; 10():. PubMed ID: 34402428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel role of CRTC2 in promoting nonalcoholic fatty liver disease.
    Han HS; Kim SG; Kim YS; Jang SH; Kwon Y; Choi D; Huh T; Moon E; Ahn E; Seong JK; Kweon HS; Hwang GS; Lee DH; Cho KW; Koo SH
    Mol Metab; 2022 Jan; 55():101402. PubMed ID: 34838715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of Secretin/Secretin Receptor Axis Ameliorates NAFLD Phenotypes.
    Chen L; Wu N; Kennedy L; Francis H; Ceci L; Zhou T; Samala N; Kyritsi K; Wu C; Sybenga A; Ekser B; Dar W; Atkins C; Meadows V; Glaser S; Alpini G
    Hepatology; 2021 Oct; 74(4):1845-1863. PubMed ID: 33928675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.